Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,468 JPY | -3.42% | -1.87% | +3.31% |
18/04 | Nxera Pharma Initiates Restricted Stock Unit Plans, Starting with Shares Worth 164 Million Yen in Total in May | MT |
17/04 | Nxera Pharma's Neuro Drug NBI-1117568 Passed Preclinical Toxicity Test | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.31% | 876M | |
-2.32% | 92.59B | |
+3.16% | 41.43B | |
-11.10% | 33.49B | |
-20.19% | 14.62B | |
-9.41% | 12.77B | |
-12.25% | 11.58B | |
-44.00% | 11.35B | |
+4.34% | 8.97B | |
-6.32% | 8.3B |
- Stock Market
- Equities
- 4565 Stock
- News Nxera Pharma Co., Ltd.
- Sosei Partner to Conduct Early Stage Trials of Neurological Disease Drug Candidates